Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
Phase 1
Recruiting
- Conditions
- Cardiovascular DisordersNeurologic DisordersIntegumentary DiseaseAutoimmune DiseasesMusculoskeletal DisordersSexual DysfunctionNeurodegenerative DisordersPulmonary DisordersUrologic DisordersDiabetes Complications
- Interventions
- Biological: PrimePro™/ PrimeMSK™
- First Posted Date
- 2020-12-24
- Last Posted Date
- 2022-04-29
- Lead Sponsor
- Thomas Advanced Medical LLC
- Target Recruit Count
- 5000
- Registration Number
- NCT04684602
- Locations
- 🇺🇸
Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites, Culver City, California, United States
Mesenchymal Stem Cells for the Treatment of COVID-19
Phase 1
Completed
- Conditions
- ProphylaxisCovid19
- Interventions
- Biological: PrimeProOther: Placebo
- First Posted Date
- 2020-10-05
- Last Posted Date
- 2020-10-05
- Lead Sponsor
- Thomas Advanced Medical LLC
- Target Recruit Count
- 40
- Registration Number
- NCT04573270
- Locations
- 🇺🇸
Southern California Hospital at Culver City / Southern California Hospital at Hollywood, Culver City, California, United States
© Copyright 2025. All Rights Reserved by MedPath